With a genetic analysis, it revealed that SMARCA4 mutations, primarily located within the SNF2‐related domain and the helicase conserved C‐terminal domain, are relatively common in lung cancer and are associated with a poorer prognosis. Here, SMARCA4 is linked to lung carcinoma.